Why Study Third-, Fourth-, Fifth-,…Line Chemotherapy of Ovarian Cancer?
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference14 articles.
1. Identification of new drugs in small cell lung cancer: phase II agents first?;Aisner;Cancer Treat Rep,1987
2. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study;Ettinger;J Natl Cancer Inst,1992
3. Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy;Gershenson;Obstet Gynecol,1989
4. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds;Gore;Gynecol Oncol,1990
5. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Defining Essential Elements of Caregiver Support in Gynecologic Cancers Using the Modified Delphi Method;Journal of Oncology Practice;2019-04
2. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy;Annals of Oncology;2012-10
3. Olaparib, PARP1 inhibitor in ovarian cancer;Expert Opinion on Investigational Drugs;2012-07-13
4. Management of Recurrent Ovarian Cancer: Chemotherapy and Clinical Trials;Early Diagnosis and Treatment of Cancer Series: Ovarian Cancer;2010
5. Optimal Management of Recurrent Ovarian Cancer;International Journal of Gynecologic Cancer;2009-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3